BrainHealth
Our flagship telehealth platform, BrainHealth.net offers a suite of tech-enabled services to address gaps in the diagnostic and care pathway. Wait times for cognitive neurology are long. We help by screening and triaging patients into appropriate workflows for healthcare providers. In addition, we offer BrainHealth members a comprehensive patient journey, including neurologist-designed preventative neurology strategies and brain health education (on nutrition, sleep, exercise, and mindfulness), lifestyle change coaching via telehealth, APOE genetic testing, biomarker testing, and information about clinical trials.
BrainHealth
Our flagship telehealth platform, BrainHealth.net offers a suite of tech-enabled services to address gaps in the diagnostic and care pathway. Wait times for cognitive neurology are long. We help by screening and triaging patients into appropriate workflows for healthcare providers. In addition, we offer BrainHealth members a comprehensive patient journey, including neurologist-designed preventative neurology strategies and brain health education (on nutrition, sleep, exercise, and mindfulness), lifestyle change coaching via telehealth, APOE genetic testing, biomarker testing, and information about clinical trials.
Access neurology diagnostics and managed telehealth services at scale
BrainHealth
Our flagship telehealth platform, BrainHealth.net offers a suite of tech-enabled services to address gaps in the diagnostic and care pathway. Wait times for cognitive neurology are long. We help by screening and triaging patients into appropriate workflows for healthcare providers. In addition, we offer BrainHealth members a comprehensive patient journey, including neurologist-designed preventative neurology strategies and brain health education (on nutrition, sleep, exercise, and mindfulness), lifestyle change coaching via telehealth, APOE genetic testing, biomarker testing, and information about clinical trials.
Afina™ Retinal Imaging
Proprietary retinal imaging platform with cloud-based AI software identifies amyloid signature in the retina, a key indicator of Alzheimer’s and Cerebral Amyloid Angiopathy (CAA). We are currently conducting groundbreaking studies to further validate our technology for prediction of CAA and ARIA, the significant side effect associated with new Alzheimer’s treatments.
